Kynurenate inhibition of cell excitation decreases stroke size and deficits

Pharmacological inhibition of excitatory neurotransmission attenuates cell death in models of global ischemia/reperfusion and hypoglycemia. The current investigations extend these observations to a model of focal ischemia. Kynurenic acid, a broad‐spectrum antagonist at excitatory amino acid receptors, was used as treatment (300 mg/kg; 3 doses at 4‐hour intervals) before and after focal cerebral ischemia in rats (n = 54). Preischemia but not 1 hour postischemia treatment with kynurenate attenuated infarction size (p < 0.001) and improved neurological outcome (p < 0.001) studied at 24 hours after injury. These data support the role of excitatory neurotransmission in acute neuronal injury and support pharmacological inhibition of cell excitation as a potential therapy for stroke.

[1]  R. Gill,et al.  Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[2]  A. Ludolph,et al.  LATHYRISM: EVIDENCE FOR ROLE OF THE NEUROEXCITATORY AMINOACID BOAA , 1986, The Lancet.

[3]  L. Pitts,et al.  Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. , 1986, Stroke.

[4]  B. Meldrum,et al.  EXCITOTOXIC MECHANISMS IN HYPOGLYCAEMIC HIPPOCAMPAL INJURY , 1986, Neuropathology and applied neurobiology.

[5]  J Astrup,et al.  Infarct Rim: Effect of Hyperglycemia on Direct Current Potential and [14C]2-Deoxyglucose Phosphorylation , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  Joseph B. Martin,et al.  Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid , 1986, Nature.

[7]  L. Pitts,et al.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.

[8]  J. Olney,et al.  Glutamate and the pathophysiology of hypoxic–ischemic brain damage , 1986, Annals of neurology.

[9]  R. Anderson,et al.  Intracellular Brain pH, Indicator Tissue Perfusion, Electroencephalography, and Histology in Severe and Moderate Focal Cortical Ischemia in the Rabbit , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  G. Fagg.  l-Glutamate, excitatory amino acid receptors and brain function , 1985, Trends in Neurosciences.

[11]  T. Wieloch.  Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. , 1985, Science.

[12]  D. Choi,et al.  Glutamate neurotoxicity in cortical cell culture is calcium dependent , 1985, Neuroscience Letters.

[13]  R. Schwarcz,et al.  EXCITATORY AMINOACID ANTAGONISTS PROVIDE A THERAPEUTIC APPROACH TO NEUROLOGICAL DISORDERS , 1985, The Lancet.

[14]  R. S. Sloviter,et al.  “Epileptic” brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine , 1985, Brain Research Bulletin.

[15]  T. Stone,et al.  Actions of kynurenic acid and quinolinic acid in the rat hippocampus in vivo , 1985, Experimental Neurology.

[16]  B. Meldrum.  Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. , 1985, Clinical science.

[17]  B. Meldrum,et al.  Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. , 1984, Science.

[18]  H. Benveniste,et al.  Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis , 1984, Journal of neurochemistry.

[19]  S. Rothman.  Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  B. Meldrum,et al.  Changes in Regional Neurotransmitter Amino Acid Levels in Rat Brain During Seizures Induced by l‐Allylglycine, Bicuculline, and Kainic Acid , 1984, Journal of neurochemistry.

[21]  G. Lombardi,et al.  The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process , 1984, Neuroscience Letters.

[22]  Carl W. Cotman,et al.  Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord , 1983, Brain Research.

[23]  C. Ribak,et al.  Five types of basket cell in the hippocampal dentate gyrus: a combined Golgi and electron microscopic study , 1983, Journal of neurocytology.

[24]  T. Stone,et al.  An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid , 1982, Brain Research.

[25]  R. Ojemann,et al.  Thresholds of focal cerebral ischemia in awake monkeys. , 1981, Journal of neurosurgery.

[26]  F. Rotenberg,et al.  COFFEE, MYOCARDIAL INFARCTION, AND SUDDEN DEATH , 1976, The Lancet.

[27]  J. Eccles,et al.  Hippocampus of the Brain: Recurrent Inhibition in the Hippocampus with Identification of the Inhibitory Cell and its Synapses , 1963, Nature.

[28]  I. Shoulson.  Huntington’s Disease: Anti-Neurotoxic Therapeutic Strategies , 1983 .

[29]  R. H. Evans,et al.  Excitatory amino acid transmitters. , 1981, Annual review of pharmacology and toxicology.